Caspofungin-resistant Aspergillus flavus after heart transplantation and mechanical circulatory support: a case

S Eschertzhuber1, C Velik-Salchner, C Hoermann

  • 1Department of Anesthesiology and Critical Care Medicine, Innsbruck Medical University, Innsbruck, Austria. stephan.eschertzhuber@uibk.ac.at

Insights

Invasive aspergillosis (IA) is a severe post-transplant complication. A cardiac transplant patient with IA developed right heart failure and died due to multi-organ failure, with resistant Aspergillus strains.

Area of Science:

  • Medicine
  • Infectious Diseases
  • Cardiology

Background:

  • Invasive aspergillosis (IA) poses a significant threat to solid organ transplant recipients.
  • Early diagnosis and targeted antifungal therapy are crucial for managing IA in this vulnerable population.

Observation:

  • A 49-year-old patient developed IA following a cardiac transplant.
  • The patient experienced severe post-transplant right heart failure, necessitating mechanical circulatory support with veno-arterial extracorporeal membrane oxygenation and a right ventricular assist device.

Findings:

  • Despite comprehensive antifungal treatment, the patient succumbed to multi-organ failure attributed to IA.
  • In vitro analysis revealed that the isolated Aspergillus strains demonstrated resistance to caspofungin, a key antifungal agent.

Implications:

  • This case highlights the critical challenges in managing IA post-cardiac transplantation, especially when complicated by cardiac dysfunction.
  • The observed in vitro resistance to caspofungin underscores the need for vigilant monitoring of antifungal susceptibility and exploration of alternative therapeutic strategies in IA cases.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...